Grifols, S.A. has signed an agreement with MassBiologics, or MBL, of the University of Massachusetts Medical School that gives Grifols exclusive rights to market and distribute MBL's tetanus and diphtheria toxoids adsorbed, or Td, vaccine in the US with the exception of Massachusetts, where MBL will continue distributing the vaccine.